Cancer Research AACR Membership  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suminami, Y.
Right arrow Articles by Kato, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suminami, Y.
Right arrow Articles by Kato, H.
[Cancer Research 61, 1776-1780, March 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Suppression of a Squamous Cell Carcinoma (SCC)-related Serpin, SCC Antigen, Inhibits Tumor Growth with Increased Intratumor Infiltration of Natural Killer Cells1

Yoshinori Suminami2, Shigeki Nagashima, Akihiro Murakami, Shugo Nawata, Toshikazu Gondo, Hiroshi Hirakawa, Fumitaka Numa, Gary A. Silverman and Hiroshi Kato

Department of Obstetrics and Gynecology [Y. S., A. M., S. Naw., H. H., F. N., H. K.] and First Department of Pathology [T. G], Yamaguchi University School of Medicine, Ube 755-8505, Japan; Department of Microbiology, Dokkyo University School of Medicine, Mibu 321-0293, Japan [S. Nag.]; and Department of Pediatrics, Harvard Medical School, Children’s Hospital, Boston, Massachusetts 02115-5737 [G. A. S.]

Squamous cell carcinoma (SCC) antigen (SCCA), a member of the ovalbumin serine proteinase inhibitor family, serves as a circulating marker of squamous cell carcinoma (SC). One of the SCCAs, SCCA1, has been suggested to play a role in the attenuation of apoptosis in vitro and in the augmentation of tumor growth in vivo. In the present study, the infection of a SCC cell line (SKG IIIa) with recombinant retrovirus that expressed the antisense SCCA mRNA suppressed expression of SCCA in vitro. Local administration of this retrovirus into tumors by inoculation in nude mice suppressed tumor growth. Treatment of tumor tissue in vivo is also associated with increased numbers of apoptotic tumor cells and large mononuclear cells in the tumor. To test the possible role of SCCA in the infiltration of large mononuclear cells, we analyzed the effect of SCCA1 on migration of natural killer (NK) cells induced by monocyte-chemoattractant protein-1 in vitro. SCCA1 suppressed migration of NK cells completely, and this inhibitory effect was lost by mutation of the reactive site loop of SCCA1. These results suggest that antisense SCCA may suppress the growth of SCC in vivo not only by the augmentation of intracellular apoptosis but also by the increased infiltration of NK cells into the tumor.




This article has been cited by other articles:


Home page
ThoraxHome page
F Calabrese, F Lunardi, C Giacometti, G Marulli, M Gnoato, P Pontisso, M Saetta, M Valente, F Rea, E Perissinotto, et al.
Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations
Thorax, September 1, 2008; 63(9): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Guido, T Roskams, P Pontisso, M Fassan, S N Thung, L Giacomelli, A Sergio, F Farinati, U Cillo, and M Rugge
Squamous cell carcinoma antigen in human liver carcinogenesis
J. Clin. Pathol., April 1, 2008; 61(4): 445 - 447.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Devoogdt, G. Hassanzadeh Ghassabeh, J. Zhang, L. Brys, P. De Baetselier, and H. Revets
Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells
PNAS, May 13, 2003; 100(10): 5778 - 5782.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Gariboldi, B. Peissel, A. Fabbri, A. Saran, D. Zaffaroni, F. S. Falvella, M. Spinola, J.-i. Tanuma, S. Pazzaglia, M. T. Mancuso, et al.
SCCA2-like Serpins Mediate Genetic Predisposition to Skin Tumors
Cancer Res., April 15, 2003; 63(8): 1871 - 1875.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Lin, Y. Nagai, R. Sladek, Y. Bastien, J. Ho, K. Petrecca, G. Sotiropoulou, E. P. Diamandis, T. J. Hudson, and J. H. White
Expression Profiling in Squamous Carcinoma Cells Reveals Pleiotropic Effects of Vitamin D3 Analog EB1089 Signaling on Cell Proliferation, Differentiation, and Immune System Regulation
Mol. Endocrinol., June 1, 2002; 16(6): 1243 - 1256.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.